…
comment: The repository administrator has not yet configured an RDF license.
primary topic: ADVANCES IN THE MANAGEMENT OF MULTIPLE SCLEROSIS: FROM IMMUNOTHERAPY TO PERSONALIZED MEDICINE

ADVANCES IN THE MANAGEMENT OF MULTIPLE SCLEROSIS: FROM IMMUNOTHERAPY TO PERSONALIZED MEDICINE
type: AcademicArticle
type: Article
abstract: Multiple sclerosis (MS) is a chronic, immune-mediated neurological disorder characterized by inflammation, demyelination, and neurodegeneration within the central nervous system. Over the past two decades, the management of MS has evolved dramatically, transitioning from limited immunomodulatory options to a broad spectrum of disease-modifying therapies and emerging personalized medicine approaches. Advances in immunotherapy have significantly reduced relapse rates and delayed disease progression, while novel biomarkers, genetic profiling, and neuroimaging techniques have enabled more individualized treatment strategies. This article reviews recent advances in the management of multiple sclerosis, focusing on immunotherapeutic developments, emerging treatment modalities, and the growing role of personalized medicine in optimizing patient outcomes.
date: 2026-02-27
status: published
author list: authors
type: EPrint
type: ArticleEPrint
is part of: repository
has document: ADVANCES IN THE MANAGEMENT OF MULTIPLE SCLEROSIS: FROM IMMUNOTHERAPY TO PERSONALIZED MEDICINE (PDF)

ADVANCES IN THE MANAGEMENT OF MULTIPLE SCLEROSIS: FROM IMMUNOTHERAPY TO PERSONALIZED MEDICINE (PDF)
type: Document
has file: main.bin
has part: main.bin
has file: 31866.pdf
has part: 31866.pdf

Research Science and Innovation house
type: Organization

MEDICINE, PEDAGOGY AND TECHNOLOGY: THEORY AND PRACTICE
type: Collection

Abduraupova Maftuna Yunusjon qizi
type: Person
given name: Abduraupova Maftuna Yunusjon
family name: qizi

HTML Summary of #83006 ADVANCES IN THE MANAGEMENT OF MULTIPLE SCLEROSIS: FROM IMMUNOTHERAPY TO PERSONALIZED MEDICINE
format: text/html
primary topic: ADVANCES IN THE MANAGEMENT OF MULTIPLE SCLEROSIS: FROM IMMUNOTHERAPY TO PERSONALIZED MEDICINE